Allarity Therapeutics Inc
NASDAQ:ALLR
Allarity Therapeutics Inc
NASDAQ:ALLR
Price:
0.965
USD
-1.12%
Market Closed
Market Cap:
$15.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Intrinsic Value
Not Available for ALLR
There is not enough data to reliably calculate the intrinsic value for Allarity Therapeutics Inc.
Do our valuations actually work? See backtest results .
Alternatives to ALLR
Fundamental Analysis
What Allarity Therapeutics Does
Allarity Therapeutics is a clinical-stage biopharmaceutical company focused on cancer medicines. It works on pairing drug candidates with a companion diagnostic approach called the Drug Response Predictor, or DRP, which is meant to help identify which patients are most likely to respond to a given therapy. The company’s work centers on turning cancer drugs into more targeted treatments rather than broad one-size-fits-all medicines.
- Headquarters
- United States of America US
- Employees
- 7
- IPO date
- Dec 21, 2021
Financials
Efficiency
Earnings Waterfall
Allarity Therapeutics Inc
Allarity Therapeutics Inc
